287 related articles for article (PubMed ID: 30643016)
21. Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer.
Altshuler E; Franke AJ; Skelton WP; Feely M; Wang Y; Lee JH; Read T; Terracina K; Lou XY; Dai Y; George TJ
Clin Colorectal Cancer; 2023 Mar; 22(1):153-159. PubMed ID: 36319582
[TBL] [Abstract][Full Text] [Related]
22. Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma.
Takeda K; Koi M; Okita Y; Sajibu S; Keku TO; Carethers JM
Cancer Res Commun; 2023 Sep; 3(9):1940-1951. PubMed ID: 37772997
[TBL] [Abstract][Full Text] [Related]
23. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic characteristics of patients with colorectal cancer from Uruguay.
Vital M; Carusso F; Vergara C; Neffa F; Della Valle A; Esperón P
Pathol Res Pract; 2023 Jan; 241():154264. PubMed ID: 36495761
[TBL] [Abstract][Full Text] [Related]
25. [Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of Colorectal Cancer in Tibet].
Luo HH; Liu BY; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Wang H; Guo PP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):184-192. PubMed ID: 38686714
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific reduction in MLH1 expression induces microsatellite instability in intestine of Mlh1
Shrestha KS; Aska EM; Tuominen MM; Kauppi L
DNA Repair (Amst); 2021 Oct; 106():103178. PubMed ID: 34311271
[TBL] [Abstract][Full Text] [Related]
27. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in Colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract][Full Text] [Related]
28. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract][Full Text] [Related]
29. Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation.
Chung C
J Oncol Pharm Pract; 2022 Jun; 28(4):850-869. PubMed ID: 33832365
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing.
Jan YH; Tan KT; Chen SJ; Yip TTC; Lu CT; Lam AK
Br J Cancer; 2022 Oct; 127(7):1304-1311. PubMed ID: 35842545
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Utilities of DNA Mismatch Repair Status and KRAS and BRAF Mutation in Korean Colorectal Cancer Patients: The KASID Multicenter Study.
Kim TW; Hwang SW; Kim KO; Cha JM; Joo YE; Cho YS
Oncology; 2023; 101(1):49-58. PubMed ID: 36191562
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability: A 2024 update.
Yamamoto H; Watanabe Y; Arai H; Umemoto K; Tateishi K; Sunakawa Y
Cancer Sci; 2024 Jun; 115(6):1738-1748. PubMed ID: 38528657
[TBL] [Abstract][Full Text] [Related]
33. BAT26 Only Microsatellite Instability with High Tumor Mutation Burden-A Rare Entity Associated with PTEN Protein Loss and High PD-L1 Expression.
Kang SY; Kim DG; Kim KM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142641
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Lee SM; Sung CO
Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
[TBL] [Abstract][Full Text] [Related]
35. Frequency and Clinicopathological Characteristics of Patients With
Uchida S; Kojima T; Sugino T
Pathol Oncol Res; 2022; 28():1610206. PubMed ID: 35280113
[No Abstract] [Full Text] [Related]
36. Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis.
Harada H; Nie Y; Araki I; Soeno T; Chuman M; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
PLoS One; 2021; 16(12):e0260303. PubMed ID: 34936649
[TBL] [Abstract][Full Text] [Related]
37. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches.
Tan E; Sahin IH
Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):735-742. PubMed ID: 33539189
[No Abstract] [Full Text] [Related]
38. The prognostic and predictive impact of
Park R; Lopes L; Lee S; Riano I; Saeed A
Future Oncol; 2021 Nov; 17(31):4221-4231. PubMed ID: 34323124
[TBL] [Abstract][Full Text] [Related]
39. The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer.
Song J; Kataoka K; Yamada T; Shiozawa M; Sonoyama T; Beppu N; Ueda K; Kuriyama S; Kanazawa A; Ikeda M; Ceelen W
Cancer Sci; 2021 Apr; 112(4):1545-1555. PubMed ID: 33484192
[TBL] [Abstract][Full Text] [Related]
40. Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma.
Baranov E; Nowak JA
Surg Pathol Clin; 2023 Dec; 16(4):635-650. PubMed ID: 37863556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
